Nasdaq smmt.
Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company operates through the Drug Development segment, which covers its research and development activities carried out by the Group. Summit Therapeutics was founded by Stephen Graham Davies and ...
Summit Therapeutics PLC (NASDAQ:SMMT)’s CEO Robert Duggan also bought a 376 million shares of the company during the same month at $1.05 per share. As of May 19, the stock is trading at $1.62.Summit Therapeutics Inc (NASDAQ:SMMT) shares are down by almost 13% year to date bringing their 12-month return to over 85%. As of this writing, Summit Therapeutics shares are trading at around $3.70 with a 52-week range of $0.66 to $5.78, giving the company a market capitalization of more than $835 million. PDS …WebSummit Therapeutics Inc (NASDAQ:SMMT) shares are down by almost 13% year to date bringing their 12-month return to over 85%. As of this writing, Summit Therapeutics shares are trading at around $3.70 with a 52-week range of $0.66 to $5.78, giving the company a market capitalization of more than $835 million. PDS …WebSummit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...WebResearch Summit Therapeutics' (Nasdaq:SMMT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...
Oxford, UK, and Cambridge, MA, US, April 30, 2020 - Summit Therapeutics plc (NASDAQ: SMMT) today reports its financial results for the fourth period * and eleven months ended December 31, 2019 ...
Oxford, UK, and Cambridge, MA, US, 15 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, presented in vivo proof of concept data for ...Nasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 …
Dhingra was up about 35.7% on the buy at the high point of today's trading session, with SMMT trading as high as $1.43 in trading on Friday. VIDEO: Friday 3/10 Insider Buying Report: UNIT, SMMTEmployees. CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company’s product pipeline includes SMT-738, a novel class of precision …Summit Therapeutics Inc NASDAQ: SMMT is a biopharmaceutical company focused on discovering, developing, and commercializing antibiotics for serious infectious ...Nov 18, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT) trade information. Upright in the green during last session for gaining 3.76%, in the last five days SMMT remained trading in the green while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $1.93 price level, adding 5.85% to its value on the day.
Share Price. NASDAQ: SMMT. 2.25USD 0.12. At 04/12/2023 19:25. More information. SEC Filings. Current report filing. VIEW FILING. Quarterly report pursuant to ...
Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Summit Therapeutics Inc. (NASDAQ:SMMT) has the sixth position on our list of the ten best penny stocks to buy in September. It is a Cambridge, Massachusetts-based clinical-stage drug discovery and ...WebMay 5, 2023 · Shares of Summit Therapeutics ( SMMT 4.93%) were up by 61.4% for the week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock, which ... Cambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual ...há 10 horas ... Price Performance Review of SMMT. On Friday, Summit Therapeutics Inc [NASDAQ:SMMT] saw its stock jump 4.93% to $2.13. On the same session, the ...30 de jul. de 2014 ... NASDAQ:SMMT. share_price_up350_53d8a4c7a8864. Shares in drug discovery firm Summit (LON:SUMM) advanced early on Wednesday as it emerged chief ...Summit Therapeutics Inc (NASDAQ:SMMT) trade information. Sporting 7.07% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, 11/14/23 when the SMMT stock price touched $1.97 or saw a rise of 0.51%.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...Web
In the last year, multiple insiders have substantially increased their holdings of Summit Therapeutics Inc. (NASDAQ:SMMT) stock, indicating that insiders' optimism about the company's prospects ...Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.WebNov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. Mar 9, 2023 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebDec 1, 2023 · See the latest Summit Therapeutics Inc Ordinary Shares stock price (SMMT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Cambridge, Massachusetts, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced the postponement of its previously announced ...WebNov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.
há 6 dias ... Get the latest Summit Therapeutics Inc. price, NASDAQ-SMMT market cap, charts, market status & all analytical data.Avenue Therapeutics Inc (NASDAQ:ATXI)’s Major holders. Insiders own 18.50% of the company shares, while shares held by institutions stand at 9.14% with a share float percentage of 11.21%. Investors are also buoyed by the number of investors in a company, with Avenue Therapeutics Inc having a total of 17 institutions that hold shares in the ...Windtree Therapeutics, Inc. (NASDAQ:WINT), Kala Pharmaceuticals, Inc. (NASDAQ:KALA), Summit Therapeutics Inc. (NASDAQ:SMMT), and GreenLight Biosciences Holdings (NASDAQ:GRNA) are some great stocks ...WebSummit Therapeutics Inc. Common Stock (SMMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ.In the last year, multiple insiders have substantially increased their holdings of Summit Therapeutics Inc. (NASDAQ:SMMT) stock, indicating that insiders' optimism about the company's prospects ...Oxford, UK, and Cambridge, MA, US, 3 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it presented results from the Phase 2 clinical trial of ridinilazole in ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...SMMT | January 20, 2023. Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the closing of our previously announced definitive agreement with Akeso Inc. (HKEX Code: 9926.HK, “Akeso”) to in-license its breakthrough bispecific antibody, ivonescimab.
Oxford, UK, and Cambridge, MA, US, 17 December 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces that Erik Ostrowski will ...
Oxford, UK, and Cambridge, MA, US, July 13, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces the publication of data from the Phase 2 clinical trial of the company’s precision ...
Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at $1.95. Approximately 87,078 shares traded hands during trading, a decline of 95% from the average daily volume of 1,810,309 shares. The stock had previously closed at $2.03. […]Mar 24, 2021 · Cambridge, MA, March 26, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the Company’s Board of Directors has approved a rights offering available to all holders of record of ... Summit Therapeutics Inc Ordinary Shares SMMT Morningstar Rating Unlock Stock XNAS Rating as of Dec 1, 2023 Summary Chart News Price vs Fair Value …Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...See the latest Summit Therapeutics Inc Ordinary Shares stock price (SMMT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.OXFORD, United Kingdom, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...WebSummit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...(NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational prog... 26 days ago - ...May 11, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts. Summit Therapeutics Inc (NASDAQ:SMMT)’s Major holders. Insiders own 29.61% of the company shares, while shares held by institutions stand at 3.27% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with Summit Therapeutics Inc having a total of 119 institutions that hold shares in the ...View the latest SMMT insider trading activity at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Summit Therapeutics (NASDAQ:SMMT) Insider Buying and Selling Activity. Current Insider Ownership Percentage 83.70%. Number Of Insiders Buying (Last 12 Months) 4. Amount Of Insider …WebSummit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...
Dec 4, 2023 · Bitdeer Technologies Holding Co (NASDAQ:BTDR)’s Major holders Insiders own 59.14% of the company shares, while shares held by institutions stand at 2.18% with a share float percentage of 5.33%. Investors are also buoyed by the number of investors in a company, with Bitdeer Technologies Holding Co having a total of 13 institutions that hold ... Menlo Park, California, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that it is nearing the previously-announced ...Dec 6, 2022 · Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ... Instagram:https://instagram. investing in carsdental insurance plans arkansasstrive asset management stock pricenew american funding heloc reviews OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) the drug discovery and development company advancing therapies for Duchenne muscular ... which banks give debit cards immediatelytax free closed end funds Menlo Park, California, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that it is nearing the previously-announced ... merger companies list (SMMT). NASDAQ: SMMT · IEX Real-Time Price · USD. Add to Watchlist. 2.13. +0.10 (4.93%). Dec 1, 2023, 4:00 PM EST - Market closed. Overview · Financials ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebSummit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ...